The current price of EOLS is $6.81 — it has increased by 0.15% since the previous close. Data as of Nov 6, 2026.
EOLS is down 7.29% over the past week, down 12.08% over the past month and up 3.73% over the past year. The price is above its 200-day moving average of $6.31.
Of the 6 analysts covering Evolus, Inc., 1 rates it a strong buy, 4 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Evolus, Inc. has a market capitalization of $449.47M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Evolus, Inc. posted a loss of $0.09 per share against an estimate of -$0.062, missing expectations by 45.16%. Upcoming reports are listed in the earnings calendar.
Evolus, Inc. reported revenue of $78M in its most recent quarter, which has increased by 13.10% compared with the same quarter a year earlier. Analysts had expected $77.58M.
Evolus, Inc. has not paid any dividends over the past year.
In the latest trading session EOLS moved between $6.57 and $6.92, a range of 5.14% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Evolus, Inc. shows a sell rating today and a strong sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Evolus, Inc. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks EOLS has traded between $3.86 and $9.31. The current price is 26.91% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.